Laurion Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Laurion Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,636	Closed	-$488K	–	1246
2020 Q1	$488K	Buy	+9,636	New	+$646K	0.01%	586
2017 Q1	–	Sell	-3,200	Closed	-$216K	–	1628
2016 Q4	$216K	Buy	+3,200	New	+$206K	﹤0.01%	984

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Laurion Capital Management's NUVA Position: Q2 2020 in Review

Laurion Capital Management sold out of NuVasive, Inc. (NUVA) in Q2 2020, closing a stake of 9,636 shares — an estimated $488K sold.

Laurion Capital Management first reported a position in NUVA in Q4 2016 and held it in 2 quarters. The position peaked at $488K in Q1 2020. 290 funds tracked by Wall St. Rank hold NUVA as of Q2 2020.

Laurion Capital Management reported no remaining NuVasive, Inc. position as of Q2 2020 after selling out during the quarter.
Laurion Capital Management sold 9,636 NuVasive, Inc. shares in Q2 2020, an estimated $488K.
Laurion Capital Management first reported a position in NuVasive, Inc. in Q4 2016 and held it in 2 quarters.
Laurion Capital Management's NuVasive, Inc. position peaked at $488K in Q1 2020.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.